
Celgene MS Drug Wins In Trial; Will Safety Top Novartis, Biogen?
Celgene got good marks for a phase three trial for its MS drug. (Kris Tripplaar/Sipa USA/Newscom) ALLISON GATLIN 2/17/2017 Reprints […]
Celgene got good marks for a phase three trial for its MS drug. (Kris Tripplaar/Sipa USA/Newscom) ALLISON GATLIN 2/17/2017 Reprints […]
0
Xconomy big apple — The FDA ended a busy week with the aid of giving a thumbs-up overdue Friday to […]
0